Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Classificação em ações #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Preço da ação
$0.17616661
Última sincronização: 2026-08-21
Valor de mercado
$73.48M
Variação (1 dia)
0.18%
Variação (1 ano)
-37.76%
País
TW
Negociar Mercury Biopharmaceutical Corporation (6932)

Categoria

Histórico de preços das ações de Mercury Biopharmaceutical Corporation (6932)
Preço de fecho mais alto: $0.19 em 2026-08-01

Preço de fecho mais baixo: $0.35 em 2022-12-01
Histórico de preços das ações da Mercury Biopharmaceutical Corporation de 2022 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -18.88%
2025 -28.11%
2024 -33.04%
2023 75.06%
2022 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN